Dr. Blake will also take part in a cancer panel during the RBC Capital Markets Global Healthcare Conference on Tuesday, February 28, 2012 at 11:00 am (Eastern) in the Holmes Room 1 of the New York Palace Hotel in New York City.
Live audio webcasts of these presentations will be available on Aeterna Zentaris' website at www.aezsinc.com, in the Newsroom section. A replay of the webcasts will also be available on the Company's website for a period of 90 days.
About Aeterna Zentaris Inc.
Aeterna Zentaris is a late-stage oncology drug development company
currently investigating potential treatments for various cancers
including colorectal, multiple myeloma, endometrial, ovarian, prostate
and bladder cancer. The Company's innovative approach of "personalized
medicine" means tailoring treatments to a patient's specific condition
and to unmet medical needs. Aeterna Zentaris' deep pipeline is drawn
from its proprietary discovery unit providing the Company with constant
and long-term access to state-of-the-art therapeutic options. For more
information please visit www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.
